WisdomTree BioRevolution Fund
WDNA
4 hedge funds and large institutions have $510K invested in WisdomTree BioRevolution Fund in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
6.14% less ownership
Funds ownership: 25.93% → 19.78% (-6.1%)
27% less capital invested
Capital invested by funds: $699K → $510K (-$190K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$267K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$5.75K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$255K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$222K |
WDNA Hedge Fund Activity: Q1 2024 in Review
4 of the 6,957 institutional investors tracked by Wall St. Rank reported a position in WisdomTree BioRevolution Fund (WDNA) for Q1 2024, worth a combined $510K — down 27% from $699K a quarter earlier.
Fund positioning in WDNA was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, adding an estimated $267K. The largest seller was Flow Traders U.S., exiting entirely with an estimated $255K sold.
- 4 institutional investors held WisdomTree BioRevolution Fund (WDNA) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $510K of WisdomTree BioRevolution Fund stock for Q1 2024, down 27% quarter-over-quarter.
- 2 funds opened new WisdomTree BioRevolution Fund positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest WisdomTree BioRevolution Fund buyer in Q1 2024 was Jane Street, an estimated $267K added.
- The largest WisdomTree BioRevolution Fund seller in Q1 2024 was Flow Traders U.S., an estimated $255K sold.
Based on aggregated 13F filings for Q1 2024.